{"id":"https://openalex.org/W2185503690","doi":"https://doi.org/","title":"Intravitreal bevacizumab in central serous chorioretinopathy.","display_name":"Intravitreal bevacizumab in central serous chorioretinopathy.","publication_year":2012,"publication_date":"2012-06-01","ids":{"openalex":"https://openalex.org/W2185503690","doi":"https://doi.org/","mag":"2185503690","pmid":"https://pubmed.ncbi.nlm.nih.gov/22630094"},"language":"en","primary_location":{"id":"pmid:22630094","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22630094","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the College of Physicians and Surgeons--Pakistan : JCPSP","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015558617","display_name":"Ahmad Zeeshan Jamil","orcid":"https://orcid.org/0000-0002-6060-1751","observed_orcids":["https://orcid.org/0000-0002-6060-1751"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmad Zeeshan Jamil","raw_affiliation_strings":["Department of Ophthalmology, Layton Rahmatullah Benevolent Trust (LRBT), Lahore. ahmadzeeshandr@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Layton Rahmatullah Benevolent Trust (LRBT), Lahore. ahmadzeeshandr@yahoo.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008265129","display_name":"Fawad Ur Rahman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fawad Ur Rahman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069378213","display_name":"Kashif Iqbal","orcid":"https://orcid.org/0000-0002-7741-4274","observed_orcids":["https://orcid.org/0000-0002-7741-4274","https://orcid.org/0009-0001-3609-3611"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kashif Iqbal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062487552","display_name":"Harris Muzammil Ansari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harris Muzammil Ansari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109053217","display_name":"Wasim Iqbal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wasim Iqbal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5011657621","display_name":"Khurram Azam Mirza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khurram Azam Mirza","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5646,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.71464304,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"22","issue":"6","first_page":"363","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/central-serous-chorioretinopathy","display_name":"central serous chorioretinopathy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9309999942779541},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9990000128746033},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.8650000095367432},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.7110000252723694},{"id":"https://openalex.org/keywords/central-macular-thickness","display_name":"central macular thickness","score":0.8769999742507935},{"id":"https://openalex.org/keywords/neurosensory-retinal-detachment","display_name":"neurosensory retinal detachment","score":0.7749999761581421},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9319999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9516639709472656},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8616132736206055},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7451501488685608},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6529644131660461},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.6443127393722534},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.602506160736084},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3082185387611389},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10907423496246338},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.08586952090263367}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018709","descriptor_name":"Statistics, Nonparametric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D056833","descriptor_name":"Central Serous Chorioretinopathy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:22630094","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22630094","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the College of Physicians and Surgeons--Pakistan : JCPSP","raw_type":"Journal Article"},{"id":"mag:2185503690","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22630094","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W107831131","https://openalex.org/W157167792","https://openalex.org/W1491922493","https://openalex.org/W1538124406","https://openalex.org/W1596870174","https://openalex.org/W1988957744","https://openalex.org/W1996375148","https://openalex.org/W2010163231","https://openalex.org/W2012648202","https://openalex.org/W2034096990","https://openalex.org/W2039936409","https://openalex.org/W2046942052","https://openalex.org/W2047943835","https://openalex.org/W2061017116","https://openalex.org/W2064327993","https://openalex.org/W2068533722","https://openalex.org/W2084833672","https://openalex.org/W2085345878","https://openalex.org/W2127023909","https://openalex.org/W2133253144","https://openalex.org/W2152676573"],"related_works":["https://openalex.org/W2338033989","https://openalex.org/W1993188396","https://openalex.org/W2995671244","https://openalex.org/W2048638761","https://openalex.org/W3001129362","https://openalex.org/W3118920367","https://openalex.org/W3042866975","https://openalex.org/W2520442922","https://openalex.org/W4386104890","https://openalex.org/W2040870282"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3],"effect":[4],"of":[5,45,60,69,87,133,151,157,188,207],"intravitreal":[6,85],"bevacizumab":[7,249],"injection":[8,86,250],"in":[9,195,202],"patients":[10,48,83,96],"with":[11,49,52,109,147,253],"central":[12,104],"serous":[13],"chorioretinopathy":[14],"(CSCR).":[15],"STUDY":[16],"DESIGN:":[17],"Quasi-experimental":[18],"study.":[19,81],"PLACE":[20],"AND":[21],"DURATION":[22],"OF":[23],"STUDY:":[24],"Layton":[25],"Rehmatullah":[26],"Benevolent":[27],"Trust":[28],"Eye":[29],"and":[30,74,93,103,123,135,143,153,176,198,221,237,256],"Cancer":[31],"Hospital,":[32],"Lahore,":[33],"from":[34,80],"July":[35],"2010":[36],"to":[37,76],"April":[38],"2011.":[39],"METHODOLOGY:":[40],"There":[41,138],"were":[42,78,114,139],"43":[43],"eyes":[44,169,179],"32":[46],"adult":[47],"CSCR.":[50],"Patients":[51],"choroidal":[53],"neovascularization,":[54],"prior":[55],"treatment":[56],"for":[57,116,131],"CSCR,":[58],"history":[59,68],"thromboembolism,":[61],"intraocular":[62,72],"pressure":[63],"more":[64,181],"than":[65,172,182],"21":[66,148],"mmHg,":[67],"retinal":[70],"detachment,":[71],"inflammation,":[73],"allergy":[75],"fluorescence":[77],"excluded":[79],"All":[82],"had":[84,97],"off":[88],"label":[89],"bevacizumab.":[90],"At":[91],"baseline":[92,218,233],"follow-up":[94],"visits,":[95],"best":[98],"corrected":[99],"visual":[100,215,254],"acuity":[101,216],"(BCVA)":[102],"macular":[105],"thickness":[106],"(CMT)":[107],"measurement":[108],"optical":[110],"coherence":[111],"tomography.":[112],"They":[113],"followed-up":[115],"6":[117,144,173,183,223,239],"months.":[118],"Outcome":[119],"measures":[120],"included":[121],"BCVA":[122,134],"CMT.":[124,136],"Wilcoxon":[125],"Signed":[126],"Ranks":[127],"test":[128],"was":[129,162,191,210,219,225,234,241,251],"used":[130],"evaluation":[132],"RESULTS:":[137],"26":[140],"(81.3%)":[141],"males":[142],"(18.7%)":[145],"females":[146],"(65.5%)":[149],"cases":[150,156,197],"unilateral":[152],"11":[154],"(34.5%)":[155],"bilateral":[158],"involvement.":[159,185],"Mean":[160,186],"age":[161],"39.09":[163],"\u00b1":[164,193,200,212],"8.49":[165],"years.":[166],"Nineteen":[167],"(59.4%)":[168],"showed":[170,180],"less":[171],"months":[174,184,224,240],"involvement":[175],"13":[177],"(40.6%)":[178],"number":[187],"injections":[189,209],"required":[190,208],"2.37":[192],"1.24":[194],"acute":[196],"3.05":[199],"1.39":[201],"chronic":[203],"cases.":[204],"Overall":[205],"mean":[206],"2.67":[211],"1.34.":[213],"Median":[214,230],"at":[217,222,232,238],"0.25":[220],"0.7":[226],"(p":[227,244],"<":[228,245],"0.001).":[229,246],"CMT":[231],"557":[235],"\u03bc":[236,243],"286":[242],"CONCLUSION:":[247],"Intravitreal":[248],"associated":[252],"improvement":[255],"reduced":[257],"neurosensory":[258],"detachment.":[259]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}